"If you ve possibly been exposed to the coronavirus (COVID-19) and are experiencing symptoms, we recommend that your first contact with a health care provider be through telemedicine. Houston Methodist Virtual Urgent Care is available 24/7- no appointment necessary. Or, if you re planning an in-person visit, please call ahead to inform your healthcare provider."

During the past decade, Houston Methodist San Jacinto Hospital conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Houston Methodist San Jacinto Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 4 trials, followed by "Alliance for Clinical Trials in Oncology" with 2 trials sponsored, "Canadian Cancer Trials Group" with 1 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 1 trials sponsored and "SWOG Cancer Research Network" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Houston Methodist San Jacinto Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 4 trials as a collaborator, "Alliance for Clinical Trials in Oncology" with 1 trials as a collaborator, "Eastern Cooperative Oncology Group" with 1 trials as a collaborator, "NRG Oncology" with 1 trials as a collaborator and "SWOG Cancer Research Network" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Houston Methodist San Jacinto Hospital" are "Invasive Breast Carcinoma" (2 trials), "Lung Non-Squamous Non-Small Cell Carcinoma" (2 trials), "Stage IIIB Lung Cancer AJCC v8" (2 trials), "ALK Gene Rearrangement" (1 trials) and "ALK Gene Translocation" (1 trials). Many other conditions were trialed in "Houston Methodist San Jacinto Hospital" in a lesser frequency.

Most popular intervention types in "Houston Methodist San Jacinto Hospital" are "Other" (8 trials), "Drug" (7 trials), "Biological" (6 trials), "Procedure" (3 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "Pembrolizumab" (4 trials), "Biospecimen Collection" (3 trials), "Carboplatin" (3 trials), "Laboratory Biomarker Analysis" (3 trials) and "Quality-of-Life Assessment" (3 trials). Other intervention names were less common.

The vast majority of trials in "Houston Methodist San Jacinto Hospital" are 8 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Houston Methodist San Jacinto Hospital". undefined are not yet recruiting, 6 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Houston Methodist San Jacinto Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Houston Methodist San Jacinto Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".